L74 logo

WuXi XDC Cayman DB:L74 Stock Report

Last Price

€3.78

Market Cap

€4.7b

7D

3.8%

1Y

6.7%

Updated

25 Dec, 2024

Data

Company Financials +

L74 Stock Overview

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. More details

L74 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance4/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

WuXi XDC Cayman Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for WuXi XDC Cayman
Historical stock prices
Current Share PriceHK$3.78
52 Week HighHK$3.84
52 Week LowHK$1.45
Beta0
1 Month Change28.57%
3 Month Change65.79%
1 Year Change6.72%
3 Year Changen/a
5 Year Changen/a
Change since IPO21.06%

Recent News & Updates

Recent updates

Shareholder Returns

L74DE Life SciencesDE Market
7D3.8%-1.4%-1.6%
1Y6.7%-5.5%6.8%

Return vs Industry: L74 exceeded the German Life Sciences industry which returned -5.6% over the past year.

Return vs Market: L74 matched the German Market which returned 6.8% over the past year.

Price Volatility

Is L74's price volatile compared to industry and market?
L74 volatility
L74 Average Weekly Movement11.3%
Life Sciences Industry Average Movement7.1%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.4%

Stable Share Price: L74's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: L74's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20131,496Jimmy Liwuxixdc.com

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. It also provides international sales contracting services.

WuXi XDC Cayman Inc. Fundamentals Summary

How do WuXi XDC Cayman's earnings and revenue compare to its market cap?
L74 fundamental statistics
Market cap€4.68b
Earnings (TTM)€78.39m
Revenue (TTM)€368.59m

59.7x

P/E Ratio

12.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
L74 income statement (TTM)
RevenueCN¥2.80b
Cost of RevenueCN¥1.93b
Gross ProfitCN¥865.49m
Other ExpensesCN¥270.94m
EarningsCN¥594.55m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.50
Gross Margin30.96%
Net Profit Margin21.27%
Debt/Equity Ratio0.8%

How did L74 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 05:16
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

WuXi XDC Cayman Inc. is covered by 19 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shun Kei LawCCB International Securities Limited
Zhishun SiuCCB International Securities Limited
Bo YuChina International Capital Corporation Limited